State MI
Clinical Trials in Michigan
Recruiting clinical trials with at least one study location in Michigan. Data updated daily from ClinicalTrials.gov.
Top Conditions in Michigan
Advanced Solid Tumor (6)Advanced Solid Tumors (5)Glioma (4)Multiple Myeloma (4)Metastatic Breast Cancer (4)Parkinson Disease (4)Stage IVB Prostate Cancer AJCC v8 (4)Breast Cancer (4)Chronic Lymphocytic Leukemia (4)Prostate Cancer (4)Non-Small Cell Lung Cancer (3)Head and Neck Squamous Cell Carcinoma (3)
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 345 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 345. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Advanced Solid Tumor, Advanced Solid Tumors, Glioma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT03949855 Phase 2
Recruiting
Belimumab With Rituximab for Primary Membranous Nephropathy
Condition
Membranous Nephropathy
Enrollment
58 pts
Location
United States
Sponsor
National Institute of Allergy
NCT07145255 Phase 1, Phase 2
Recruiting
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Condition
Prostate Cancer Castration-resistant Prostate Cancer
Enrollment
150 pts
Location
United States
Sponsor
MBrace Therapeutics
NCT05145491 N/A
Recruiting
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
Condition
Epiretinal Membrane
Enrollment
400 pts
Location
United States, United Kingdom
Sponsor
Jaeb Center for Health Researc
NCT06012240 Phase 3
Recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adul...
Condition
Alopecia Areata
Enrollment
1,500 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie
NCT05133102 N/A
Recruiting
Longitudinal Oral Microbiome Sampling for BE
Condition
Barrett Esophagus
Enrollment
275 pts
Location
United States
Sponsor
Columbia University
NCT07225101 Phase 4
Recruiting
Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Proc...
Condition
Wound Closure
Enrollment
160 pts
Location
United States
Sponsor
University of Michigan
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT06107881 N/A
Recruiting
Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST...
Condition
Low Vision
Enrollment
350 pts
Location
United States
Sponsor
University of California, Los
NCT05603728 N/A
Recruiting
Exactech Shoulder Post Market Clinical Follow-up Study
Condition
Osteo Arthritis Shoulders
Enrollment
20,000 pts
Location
United States, Canada, France
Sponsor
Exactech
NCT06685757 Phase 3
Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in A...
Condition
Antibody-mediated Rejection
Enrollment
120 pts
Location
United States, Argentina, Australia
Sponsor
Biogen
NCT05646381 Phase 2
Recruiting
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacar...
Condition
Aortic Stenosis
Enrollment
502 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT04627428 Phase 1, Phase 2
Recruiting
Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation ...
Condition
Dry Age-related Macular Degeneration
Enrollment
18 pts
Location
United States
Sponsor
Luxa Biotechnology, LLC
NCT00246857 N/A
Recruiting
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed...
Condition
Primary Immune Deficiency
Enrollment
5,000 pts
Location
United States, Turkey (Türkiye)
Sponsor
National Institute of Allergy
NCT06690801 N/A
Recruiting
Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Synd...
Condition
Acute Respiratory Distress Syndrome
Enrollment
1,260 pts
Location
United States
Sponsor
Children's Hospital Los Angele
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
NCT03871075 N/A
Recruiting
Intermittent Pneumatic Compression With and Without Exercise to Improve Function...
Condition
Peripheral Artery Disease
Enrollment
230 pts
Location
United States
Sponsor
Northwestern University
NCT06307977 N/A
Recruiting
Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable ...
Condition
Substance Use
Enrollment
360 pts
Location
United States
Sponsor
Hunter College of City Univers
NCT05901519 Phase 2
Recruiting
A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereo...
Condition
Hepatocellular Carcinoma
Enrollment
20 pts
Location
United States
Sponsor
University of Michigan Rogel C
NCT05904028 Phase 3
Recruiting
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascu...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
600 pts
Location
United States, Canada
Sponsor
Jaeb Center for Health Researc
NCT05941507 Phase 1, Phase 2
Recruiting
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti...
Condition
Advanced Solid Tumors
Enrollment
300 pts
Location
United States, Canada
Sponsor
LigaChem Biosciences, Inc.
NCT07000357 Phase 3
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a Histo...
Condition
Cardiovascular Disease
Enrollment
15,100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT06052267 Phase 3
Recruiting
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol ...
Condition
Asthma
Enrollment
2,700 pts
Location
United States, Argentina, Australia
Sponsor
Teva Branded Pharmaceutical Pr
NCT06084234 Phase 4
Recruiting
National Liver Cancer Screening Trial
Condition
Carcinoma, Hepatocellular
Enrollment
5,500 pts
Location
United States
Sponsor
University of Texas Southweste
NCT01193075 N/A
Recruiting
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT...
Condition
Charcot Marie Tooth Disease
Enrollment
5,000 pts
Location
United States, Australia, Canada
Sponsor
Michael Shy
NCT06526195 N/A
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in ...
Condition
Heart Failure
Enrollment
850 pts
Location
United States, Austria, Czechia
Sponsor
Abbott Medical Devices
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology